NCT01879241 Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT01854294 GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) Status COMPLETED Phase PHASE2
NCT01823380 Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype Status COMPLETED Phase NA
NCT01777646 Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT01771640 Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS Status COMPLETED Phase PHASE1
NCT01759797 Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS Status COMPLETED Phase PHASE1
NCT01759784 Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS Status WITHDRAWN Phase PHASE1
NCT01758510 Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT01753076 Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT01730716 Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis Status UNKNOWN Phase PHASE2
NCT01709149 Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT01641965 Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Patients Status COMPLETED Phase NA
NCT01640067 Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE1
NCT01639391 Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study Status COMPLETED Phase NA